CAS 3029443-36-2

Fórmula: C34H33F6N7O3S

InChI: InChI=1S/C34H33F6N7O3S/c1-3-47(18-7-10-45(15-18)32(48)49-2)30-20-11-22(34(38,39)40)25(19-5-6-23(36)28-24(19)21(13-41)29(42)51-28)26(37)27(20)43-31(44-30)50-16-33-8-4-9-46(33)14-17(35)12-33/h5-6,11,17-18H,3-4,7-10,12,14-16,42H2,1-2H3/t17-,18+,33+/m1/s1

Chave InChI: VJMZMAQRBQSNHW-AXZPFCHASA-N

SMILES: CCN([C@H]1CCN(C1)C(=O)OC)C2=NC(=NC3=C(C(=C(C=C32)C(F)(F)F)C4=C5C(=C(SC5=C(C=C4)F)N)C#N)F)OC[C@@]67CCCN6C[C@@H](C7)F

BBO-11818

CAS: 3029443-36-2

BBO-11818

Fórmula: C₃₄H₃₃F₆N₇O₃S

Pureza: 98%

Peso molecular: 733.73

Ref: 54-BUP24254

Methyl 3-((7-(2-amino-3-cyano-7-fluorobenzo[b]thiophen-4-yl)-8-fluoro-2-((2-fluorotetrahydro-1H-pyrrolizin-7a(5H)-yl)methoxy)-6-(trifluoromethyl)quinazolin-4-yl)(ethyl)amino)pyrrolidine-1-carboxylate

CAS: 3029443-36-2

Fórmula: C₃₄H₃₃F₆N₇O₃S

Pureza: 98%

Cor e Forma: Solid

Peso molecular: 733.7263

Ref: IN-DA0IH57V

BBO-11818

CAS: 3029443-36-2

BBO-11818 is an oral pan-KRAS inhibitor suppressing MAPK/ERK signaling.

Fórmula: C₃₄H₃₃F₆N₇O₃S

Pureza: 98.19%

Peso molecular: 733.73

Ref: TM-T217533